Partners 2026

National Lab partner

PureLab, a PureHealth asset, operates and manages the largest network of laboratories in the region; these also include the largest network of ISO Accredited Laboratories currently totalling over 160+ labs across the UAE. PureLab, is a comprehensive laboratory operation that supports both the public and private sectors by providing the largest in-house test menu. PureLab leverages economies of scale with our high volume of tests (over 25 million tests conducted per year) and runs an agile operation that ensures accurate, reliable, and timely diagnostics, delivered to our customers. The company also plays a pivotal role in using its laboratory diagnostics network to conduct public screening programmes and population health management, as well as spearheading COVID-19 screening efforts in the UAE. Bringing in unparalleled efficiencies and redefining industry standards, PureLab has proven itself as a partner of choice.

Innovation partner

Since its establishment in 1995, Snibe has contributed to the development of the IVD field through Chemiluminescence immunoassay products. Focusing on Chemiluminescence immunoassay solutions over 28 years, Snibe’s total installations currently reach 23,900 units, with products exported to more than 150 countries globally. At present, Snibe has 3 main product lines: Immunoassay, Clinical chemistry and Molecular diagnosis, providing diversified total laboratory automation solutions. Meanwhile, Snibe’s Auto-immunoassay analyzer Maglumi X8 has the fastest throughput which can reach up to 600 tests per hour. Snibe also owns a broad CLIA test menu of up to 194 parameters, as well as a fully automated production line with an annual productivity of 4 million reagent kits. Outstanding product quality is inseparable from the support of brilliant talents. In pursuing the best quality and best service, Snibe has established a Reagents R&D and Production center, Instruments R&D and Production center, and Sales & Marketing center to form a strong team of professionals, among which professional R&D personnel accounts for more than 16%. To be the pioneer in the global diagnosis field is Snibe's vision. Their strive for excellence never ends.

Smart Lab partner

Sysmex is a global leader in medical diagnostics, guided by its long-term vision: together for better healthcare journey. With more than 50 years of expertise in in-vitro diagnostics and beyond, we are continuously developing our product and service portfolio to cover the entire care pathway and empower healthcare professionals to provide the best possible patient care. Sysmex Middle East FZ-LLC is a subsidiary of Sysmex Europe SE, headquartered in Hamburg, Germany, and was established in April 2008 as a regional hub for Middle Eastern markets. Sysmex Middle East operates through four regional entities, with direct affiliates in Saudi Arabia and Egypt, ensuring strong local presence, high quality customer support and expert technical service. Committed to advancing healthcare through knowledge, technology, and innovation, Sysmex places strong emphasis on high-level training, service and support. Its value-enhancing services provide customers with a personalised approach, ranging from standalone diagnostic solutions to fully integrated managed service agreements.

A global leader in clinical diagnostics, Beckman Coulter Diagnostics has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. The company’s mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and this is done by applying the power of science, technology and the passion and creativity of their teams. The company’s diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. They exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. This is done by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, California, with more than 11,000 global team members.

Beckman Coulter Diagnostics is proud to be part of Danaher. Danaher’s science and technology leadership puts Beckman Coulter Diagnostics’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means Beckman Coulter Diagnostics can offer unparalleled breadth and depth of expertise and solutions to their customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, Beckman Coulter Diagnostics unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

Randox is a global leader in healthcare diagnostics, dedicated to improving patient outcomes through innovation, accuracy, and scientific excellence. Founded in 1982 and headquartered in Northern Ireland, Randox delivers cutting-edge diagnostic solutions to healthcare providers, laboratories, and consumers in over 145 countries. Its extensive portfolio spans clinical chemistry, immunoassay, molecular diagnostics, toxicology, veterinary testing, and quality control, underpinned by its proprietary Biochip Array Technology, which enables multiple tests from a single patient sample.

Driven by a strong commitment to research and development, Randox continually expands its test menu to address emerging health challenges and advance personalised medicine. The company also operates Randox Health clinics, bringing preventative healthcare and advanced testing directly to consumers. Recognised globally for quality, reliability, and innovation, Randox plays a vital role in supporting clinicians, laboratories, and public health systems to deliver faster, smarter, and more effective diagnostic solutions worldwide.

Two decades ago, AGD Biomedicals Pvt. Ltd. started with the aim of providing the best healthcare systems in the world. Today, the company stands among the most trusted names in global healthcare.

AGD Biomedicals is ISO 9001:2015 certified for consistent customer-satisfaction and regulatory conformance, and ISO 13485:2016 certified for manufacture, export, import, sales and service of the entire range of laboratory diagnostic instruments and reagents.

Al Fahim Healthcare Solutions LLC is a leading laboratory diagnostic supplies company in the UAE based out of Dubai. We cater to hospitals, laboratories, and referral laboratories in both the private and government sectors. The company's services are also tailored to meet the needs of universities and food industries like dairy and meat processing facilities. Al Fahim Healthcare Solutions LLC distributes products for some of the largest municipalities in the UAE and is the exclusive distributor for several major brands in the laboratory diagnostics and microbiology industries.

The company has a significant healthcare market share, with over 20,000 products in its portfolio and operations in both government and private sectors. At Al Fahim Healthcare Solutions LLC, they take great pride in their reputation for offering valued customers high-quality medical supplies, laboratory diagnostic products, and healthcare testing instruments.

Al Hayat Pharmaceuticals LLC SP (AHP) is a trusted leader in the distribution of high-quality pharmaceuticals, medical, dental, and laboratory equipment throughout the UAE.

With over 40 years of dedicated service, the company is committed to delivering innovative healthcare solutions that empower clinics, hospitals, and laboratories to provide exceptional care.

BIOBASE is a high-tech enterprise whose business covers biomedical, e-commerce, intelligent manufacturing, scientific equipment, In Vitro Diagnosis (IVD) instruments and reagents.

With more than 5,000 people and 31 workshops, covering a total area of 932,900 m2, BIOBASE has established companies in the USA, UAE, India, Algeria, Singapore, Myanmar and other countries. BIOBASE is specialized in medical equipment and laboratory equipment products, with more than 200 existing high-tech products.

Since 1993 the DNA-Technology Group has been developing, producing and introducing high-tech equipment and reagents for PCR analysis. The company's products are supplied to hospitals and laboratories through a global distribution network in more than 45 countries all over the world.

Their goal is to apply the latest scientific discoveries in the field of molecular biology methods to routine laboratory practice to improve diagnostic quality for effective treatment and the prognosis of clinical outcome more precise. The company is certified in accordance with ISO 13485:2016, ISO 9001:2015. The manufactured products conform regulatory requirements for IVD Medical Devices (Directive 98/79/EC) and CE IVD certified.

Life Diagnostics has offered patients world-class laboratory and radiology services in the heart of Abu Dhabi for over 20 years. ISO15189 accreditation exceeds Life Diagnostic’s gold standards to offer patients and clients the highest level of quality, safety, and reliability. The company provides a broad range of high-quality and cost-effective routine and specialized services that include Anatomic Pathology and Cytology, Microbiology, Chemistry and Immunoassay, Hematology, Molecular Biology and Radiology.

The company's accurate results and service offerings have led them to expand at a fast pace since we first opened all while maintaining the same level of quality. Beyond lab results, Life Diagnostics builds relationships and create collaborative partnerships with the communities they serve. The company works closely and collaboratively with private and governmental companies, airlines, pharmaceutical companies, hospitals, laboratories, medical centers, and physicians.

Mindray is a leading global designer, developer, and manufacturer of medical devices and solutions, dedicated to making better healthcare more accessible to humanity. Since its foundation in 1991, Mindray has been exclusively focused on the medical industry in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging.

Headquartered in Shenzhen China, Mindray is a multinational corporation with subsidiaries in almost 40 countries in North and South America, Europe, Africa, and the Asia-Pacific region. Its products and services are available in over 190 countries.

QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence. Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us. QuidelOrtho is advancing diagnostics to power a healthier future.

Anbio Biotechnology is a global medical device company specializing in in vitro diagnostics (IVD), with a strong focus on point-of-care testing (POCT). We aim to personalize and decentralize diagnostics by delivering rapid, accessible, and affordable POCT and laboratory solutions that enable earlier diagnosis and improved patient outcomes.

With robust capabilities in R&D, manufacturing, and global distribution, Anbio provides cost-effective diagnostic solutions for hospitals, clinics, and decentralized care settings worldwide. Our POCT-driven product portfolio spans oncology, cardiovascular disease, pharmacogenomics, hormones, infectious diseases, inflammation, and drugs of abuse testing — empowering healthcare providers to make faster clinical decisions wherever care is delivered.

FL Medical is an Italian leading laboratory equipment manufacturer that has been producing laboratory products for medical technology since 1979.

They have been successful year after year by manufacturing medical laboratory equipment constantly improved through hard work. FL Medical offers customers not only high-quality medical lab equipment but experience, professionalism and the broadest guarantees, too.

In 2014, Fujifilm established “Value from Innovation” as our corporate slogan, declaring our company‘s commitment to continue producing innovative new technologies, products and services. In line with the slogan, in 2018 we launched a new global branding campaign entitled NEVER STOP highlighting Fujifilm‘s commitment to providing new value through innovative advanced technologies, contributing to the solution of various issues facing society, while also declaring a commitment to NEVER STOP producing value through innovation, a strong statement of Fujifilm‘s ambition and approach which this campaign will communicate to people around the world. Our message is clear.

For more than 80 years, we‘ve continued to transform ourselves. Building from our origins as a photographic film, we evolved into a technology company working in areas such as healthcare, highly functional materials, imaging solutions, document solutions and more. In healthcare, Fujifilm is engaged in prevention, diagnosis, and treatment. We are pioneering the world of biopharmaceuticals and regenerative medicine, while also developing revolutionary healthcare IT, allowing medical professionals to make more precise diagnoses more quickly. By leveraging our advanced and unique technologies, we will continue creating value from innovation and contribute to solving social challenges. This means we‘ll never stop building on our experience and expertise to help transform ourselves, and the world.

Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While they discover and develop groundbreaking products and services that benefit everyone, the company is especially passionate about those that advance women’s health and well-being.

Hologic develops life-changing medical technologies designed to achieve exceptional clinical results and help healthcare professionals treat each patient with ever-greater certainty.

Founded in 1953, HORIBA has explored a wide range of unique measurement and analysis technologies to meet global customer needs from group companies and local sites spread across 29 countries and regions. Under the corporate motto Joy and Fun, the company has expanded and refined its core technologies to solve society’s energy issues of today and tomorrow.

Their unique measurement and analysis technologies are valued in various fields of society including the three megatrend business fields of Energy & Environment, Biology & Healthcare and Materials & Semiconductor.

Leader Life Sciences started with a simple belief: technology should make scientists’ lives easier, more efficient and more impactful. In 2020, as the world faced the COVID-19 crisis, Leader Life Sciences began its journey, providing critical solutions to support researchers and healthcare professionals across the region. With the vision of CEO Sukhdeep Sachdev, he laid the foundation for a company that would grow into a trusted ally for the scientific community.

The company is committed to being the region’s leading partner in scientific research and diagnostics, introducing innovative technologies that transform the way scientists work, discover, and collaborate. Leader Life Sciences' tagline, Partners in Discovery, captures the spirit of everything they do. It reflects the company's belief that real progress happens through collaboration, that when technology providers, researchers, and institutions work as one, the path to scientific breakthroughs becomes more impactful.

MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI) is committed to building core tools and technologies that drive innovation in life science. The company's focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. MGI provides real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries.

Founded in 2016, MGI has emerged as a global leader, operating on six continents with facilities for research, manufacturing, training, and after-sales service. Notably, MGI is among the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with diverse throughput capacities. As of June 30, 2024, MGI employs over 2,670 people, with approximately 32.16% in research and development. Operating in over 100 countries, MGI serves more than 3,000 users, showcasing its commitment to shaping the future of life sciences.

Every day around the world, millions of people are tested for infectious diseases – whether it be influenza, Hepatitis, HIV or COVID-19. Keeping us all safe and well relies on the accuracy of this testing. NRL is a global leader in the science of quality for infectious disease testing. The not-for-profit scientific organisation supports laboratories in more than 70 countries to ensure their results are accurate, consistent and reliable. From a new laboratory in London, to a point-of-care test in Mongolia, from a blood bank in Manila to a public laboratory in Melbourne – NRL’s mission is to create healthy communities across the globe, through supporting accurate, high-quality infectious disease testing.

NRL provides a range of complementary services: Highly sophisticated quality assurance programs (quality control samples and monitoring software; international proficiency testing programs to 2000+ laboratories in 70+ countries); Pre- and post-market evaluations of IVDs and associated sample panels; Specialised and reference testing services, licensed to cGMP; Biobanking expertise and a significant disease-state plasma repository; Laboratory capacity and capability building in low- and middle-income countries; Educational workshops and seminars, mentoring and consultancy; Global research collaborations

Seegene is a global leader in biotechnology, based in South Korea, with seven international subsidiaries, including one in the UAE. Seegene specializes in molecular diagnostic solutions, particularly in the development of high multiplex PCR technology.

Seegene tirelessly pursues innovation and takes on new challenges to build a better future for humanity. Seegene has produced and delivered molecular diagnostics (MDx) products capable of detecting multiple targets simultaneously. Seegene’s high multiplex assays deliver comprehensive clinical information in a single test and allow accurate and rapid diagnosis.

Wantai BioPharm, established in 1991, is a premier high-tech enterprise dedicated to the research, development, and manufacturing of innovative In Vitro Diagnostic (IVD) solutions and vaccines. Driven by the mission "Advancing Human Health Through Biotechnology," Wantai translates scientific breakthroughs into high-quality healthcare tools that improve lives worldwide.

With a diverse portfolio spanning Chemiluminescence (CLIA), ELISA, POCT, Molecular Diagnostics, and Clinical Chemistry, Wantai provides comprehensive laboratory solutions alongside pioneering work in vaccine development. Supported by 9 specialized subsidiaries, the company maintains a rigorous focus on scientific excellence and high-standard production. Today, Wantai’s global footprint extends to over 80 countries, where it serves as a trusted partner for hospitals, blood banks, and public health organizations. Through continuous innovation, Wantai remains dedicated to delivering efficient, reliable medical diagnostics that empower healthcare professionals and enhance patient outcomes globally.